Lotus Jeffs, a PhD student from Monash University, discusses the intriguing effects of Ozempic on appetite suppression. She explains how GLP-1 agonists, inspired by lizard venom, work in the brain to reduce cravings for unhealthy foods. The conversation dives into the physiological and psychological changes these drugs induce, alongside challenges in drug approvals due to potential health risks. Jeffs also highlights the surprising mental health implications, including concerns about depression and their potential for new therapeutic uses.
